PharmARC makes appointment
This article was originally published in Scrip
PharmARC, a wholly-owned subsidiary of PharmARC Analytic Solutions, has appointed Andreas Sommersenior manager-business development, US operations. He has experience in direct selling, product management, and operational excellence. Mr Sommer was previously with Merck and Co Inc, where he previously held the position of Merck Six Sigma manager.
You may also be interested in...
Eris Lifesciences has acquired a Novartis trademark for vildagliptin, a DPP-4 inhibitor that has been the subject of a torrent of alleged infringement-related legal action in India. Pricing for the acquired brand will be interesting to watch from now on as a patent on vildagliptin is set to expire soon.
Cipla’s global chief operating officer is leaving the company to pursue new interests, amid a spate of top-level exits that have marked the pharma sector in India in 2019.